Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Keratins 6, 16, and 17 increase in damaged or diseased skin and may help diagnose skin issues.

Recent progress has been made in understanding inherited hair and nail disorders.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Thyroid hormones are important for skin health and might help treat skin diseases, but more research is needed to understand their effects fully.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

Feathers become harder as they develop due to a change in keratin type.

Erlotinib can cause hair loss as a side effect.

Hair is mostly made of three protein types: helical, high-sulfur, and high-tyrosine.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Hair keratins evolved from ancient proteins, diversifying through gene changes, crucial for forming claws and later hair in mammals.

Keratin gene clusters in humans and marsupials are similarly organized.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Keratins are crucial for hair strength, and mutations in certain keratin genes cause hair disorders.

The document concludes that over 500 genes are linked to hair disorders and this knowledge is important for creating new treatments.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

EGFR inhibitors can cause yellowish skin eruptions.

Older adults have a wide range of skin conditions, with dry skin being very common and many also experiencing skin growths, itching, and infections.

Hair and wool have diverse keratins and keratin-associated proteins.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Enzymatic phosphorylation of hair keratin improves the effectiveness of hair products with cationic ingredients.

Hair microscopy is useful for diagnosing hair disorders, but clear definitions are needed for accurate genetic analysis.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.